Cicatridina®
Cicatridina® ovules is indicated for the adjuvant treatment of reparative processes in atrophic and dystrophic conditions of the vaginal mucosa. It contributes to postpartum healing, in gynecological surgery, in cases of dystrophy derived from chemotherapy, ionizing radiation, vaginal dryness also due to to estrogen deficiency.
Cicatridina® suppositories is indicated in:
SIDE EFFECTS: The use of any topical product, especially if prolonged, may cause sensitization. If this occurs, discontinue treatment and consult your physician to initiate appropriate therapy. If other undesirable effects occur, inform your doctor or pharmacist.
WARNINGS: Keep out of the reach of children. Avoid contact with eyes. Do not swallow.
Download Instructions for Use IFU Cicatridina suppositories Download Instructions for Use IFU Cicatridina ovulesCicatridina®
Ownership: FARMA-DERMA s.r.l
Comercialized by: Marketed and distributed in Spain by Laboratorios Rubió as a local representative.
Last update: July 2024
The information contained in this area is directed exclusively to healthcare professionals with the capacity to prescribe or dispense medications.